Navigation Links
Gamida Cell Announces $4.4 Million Grant from the Israeli Government
Date:5/23/2016

JERUSALEM, May 23, 2016 /PRNewswire/ --

Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today it has been awarded a grant of up to $4.4 million from the Israel Innovation Authority (formerly the Office of the Chief Scientist) of the Israeli Ministry of Economy and Industry. The mission of the Israel Innovation Authority is to encourage innovation and entrepreneurship in various industries, including science and technology, while stimulating economic growth.

The non-dilutive funding will support Gamida Cell's ongoing research and development efforts including its Phase 3 registration study of NiCord® for hematological malignancies (blood cancers like leukemia and lymphoma), and its clinical trials of CordIn® for sickle cell disease and thalassemia and NK cells as a potential immune therapy for cancer.

"We are very pleased to have received this grant and know it will contribute to our broad clinical development plans for this year, which include the launch of a registration study for our lead program and early clinical stage work on our immuno-oncology candidate. The grant announced today is the largest amount we have been rewarded to date. We feel it is a clear demonstration of the Innovation Authority's ongoing confidence and trust in our important mission," said Dr. Yael Margolin, Gamida Cell's president and CEO.

About Gamida Cell  

Gamida Cell is a world leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases. The company's pipeline of products are in development to treat a wide range of conditions including cancer, genetic hematological diseases such as sickle cell disease and thalassemia, bone marrow failure syndromes such as aplastic anemia, genetic metabolic diseases and refractory autoimmune diseases. Gamida Cell's current shareholders include: Novartis, Elbit Imaging, Clal Biotechnology Industries, Israel Healthcare Venture, Teva Pharmaceutical Industries, Denali Ventures and Auriga Ventures.   For more information please visit http://www.gamida-cell.com.

Press Contact:
Marjie Hadad
MH Communications
+972-54-536-5220
marjierhadad@gmail.com

Investor Contact:
Beth DelGiacco
Stern Investor Relations, Inc.
+1-212-362-1200
beth@sternir.com


'/>"/>
SOURCE Gamida Cell
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
2. Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company
3. Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
4. Purdue Pharma Announces Patent Agreement with Egalet and Acura
5. DS Biopharma Announces DS102 will be Developed for Pulmonary Disorders in Addition to NASH
6. Mauna Kea Technologies Announces Strong Presence of Cellvizio Platform at Major Medical Meetings Focused on Gastroenterology
7. Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Associations 21st Congress
8. Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study
9. Lightpoint Medical Announces Exclusive Global License Agreement With the University of Arizona to Develop Molecular Imaging Technology
10. New Colombia Resources Sannabis Subsidiary Announces Filing for Medical Marijuana Licenses With the Ministry of Justice in order to Export Products
11. Aptuit Announces Acquisition of Kuecept Ltd
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2019)... ... July 11, 2019 , ... Voted one of “The ... by a luminary of the cosmetic world to “represent a revolutionary scientific breakthrough ... DELTA-5, derived from exotic conifer seeds. DELTA-5 technology works to reduce pro-inflammatory eicosanoid ...
(Date:7/11/2019)... TEMPE, Ariz. (PRWEB) , ... July 11, 2019 ... ... cycle management, has entered into a strategic partnership with Palmer College of Chiropractic, ... a thorough vetting process, Nobility has been specially selected to handle its billing ...
(Date:7/10/2019)... ... July 10, 2019 , ... Medisend College ... the Zoe Geh Hospital located in rural Liberia, one of the poorest countries ... students in the biomedical engineering technology courses at Medisend College to have a ...
Breaking Medicine Technology:
(Date:7/9/2019)... ... July 09, 2019 , ... Advanced Intelligent Systems ... solve labour shortage problems in agriculture, will demonstrate their flagship autonomous custom robot, ... Cultivate’19 is North America’s leading trade show for the horticulture industry. , ...
(Date:7/9/2019)... ... 2019 , ... EveryPig , the intelligent pig health ... a new strategic partnership with Glacier Pig Management. Together, the companies will break ... swine industry. The partnership is the result of a Distribution Agreement between the ...
(Date:7/9/2019)... ... ... Fonolo , the leader in cloud-based call-back solutions for the contact center, today ... Your Call Center for Seasonal Call Spikes: Healthcare Edition . The new publication provides ... year: Open enrollment. , Open enrollment is one of the busiest and most stressful ...
(Date:7/9/2019)... SARASOTA, Fla. (PRWEB) , ... July 08, 2019 , ... ... specializing in implants and periodontal care in the East Valley of Arizona. With two ... in Phoenix Magazine since 2004. , Established in 2003, EVIP is led by ...
(Date:7/9/2019)... South Korea (PRWEB) , ... July 09, 2019 , ... ... many products on the market today are made from high-quality ingredients, the effects that ... Bio Labs, led by CEO Dr. Jae Hyun Sim and CTO Jun Sim were ...
Breaking Medicine News(10 mins):